Metropolitan Life Insurance Company (MetLife)’s Align Technology ALGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,873
| Closed | -$942K | – | 93 |
|
|
2024
Q1 | $942K | Sell |
2,873
-26
| -0.9% | -$7.63K | 0.04% | 344 |
|
|
2023
Q4 | $794K | Sell |
2,899
-46
| -2% | -$10.9K | 0.04% | 358 |
|
|
2023
Q3 | $899K | Sell |
2,945
-156
| -5% | -$53.9K | 0.05% | 319 |
|
|
2023
Q2 | $1.1M | Sell |
3,101
-149
| -5% | -$47.4K | 0.05% | 304 |
|
|
2023
Q1 | $1.09M | Sell |
3,250
-952
| -23% | -$281K | 0.06% | 306 |
|
|
2022
Q4 | $886K | Buy |
4,202
+31
| +0.7% | +$6.21K | 0.04% | 387 |
|
|
2022
Q3 | $864K | Sell |
4,171
-90
| -2% | -$23.2K | 0.04% | 384 |
|
|
2022
Q2 | $1.01M | Sell |
4,261
-111
| -3% | -$34.1K | 0.04% | 366 |
|
|
2022
Q1 | $1.91M | Sell |
4,372
-7,635
| -64% | -$3.72M | 0.07% | 269 |
|
|
2021
Q4 | $7.89M | Sell |
12,007
-294
| -2% | -$189K | 0.11% | 147 |
|
|
2021
Q3 | $8.19M | Sell |
12,301
-265
| -2% | -$180K | 0.12% | 138 |
|
|
2021
Q2 | $7.68M | Sell |
12,566
-368
| -3% | -$218K | 0.11% | 148 |
|
|
2021
Q1 | $7M | Sell |
12,934
-719
| -5% | -$397K | 0.1% | 156 |
|
|
2020
Q4 | $7.3M | Sell |
13,653
-522
| -4% | -$235K | 0.11% | 151 |
|
|
2020
Q3 | $4.64M | Sell |
14,175
-567
| -4% | -$173K | 0.08% | 201 |
|
|
2020
Q2 | $4.05M | Buy |
14,742
+366
| +3% | +$82.4K | 0.07% | 217 |
|
|
2020
Q1 | $2.5M | Sell |
14,376
-214
| -1% | -$51.2K | 0.05% | 316 |
|
|
2019
Q4 | $4.07M | Sell |
14,590
-394
| -3% | -$98.2K | 0.07% | 257 |
|
|
2019
Q3 | $2.71M | Buy |
14,984
+13
| +0.1% | +$2.7K | 0.05% | 355 |
|
|
2019
Q2 | $4.1M | Buy |
14,971
+643
| +4% | +$194K | 0.07% | 242 |
|
|
2019
Q1 | $4.07M | Sell |
14,328
-460
| -3% | -$110K | 0.07% | 222 |
|
|
2018
Q4 | $3.1M | Sell |
14,788
-3
| -0% | -$758 | 0.06% | 255 |
|
|
2018
Q3 | $5.79M | Sell |
14,791
-226
| -2% | -$83.4K | 0.1% | 175 |
|
|
2018
Q2 | $5.14M | Buy |
15,017
+129
| +0.9% | +$38.5K | 0.08% | 206 |
|
|
2018
Q1 | $3.74M | Buy |
14,888
+61
| +0.4% | +$15.7K | 0.05% | 264 |
|
|
2017
Q4 | $3.29M | Sell |
14,827
-23,032
| -61% | -$5.23M | 0.04% | 305 |
|
|
2017
Q3 | $7.05M | Sell |
37,859
-1,973
| -5% | -$338K | 0.04% | 372 |
|
|
2017
Q2 | $5.98M | Sell |
39,832
-33,291
| -46% | -$4.51M | 0.04% | 464 |
|
|
2017
Q1 | $8.39M | Buy |
73,123
+318
| +0.4% | +$32.1K | 0.06% | 322 |
|
|
2016
Q4 | $7M | Sell |
72,805
-747
| -1% | -$69.4K | 0.05% | 376 |
|
|
2016
Q3 | $6.9M | Buy |
73,552
+1,738
| +2% | +$157K | 0.05% | 372 |
|
|
2016
Q2 | $5.79M | Buy |
71,814
+2,202
| +3% | +$168K | 0.04% | 442 |
|
|
2016
Q1 | $5.06M | Buy |
69,612
+1,963
| +3% | +$129K | 0.04% | 508 |
|
|
2015
Q4 | $4.46M | Sell |
67,649
-29
| -0% | -$1.86K | 0.03% | 555 |
|
|
2015
Q3 | $3.84M | Sell |
67,678
-392
| -0.6% | -$23.4K | 0.03% | 624 |
|
|
2015
Q2 | $4.27M | Buy |
68,070
+471
| +0.7% | +$27.8K | 0.03% | 620 |
|
|
2015
Q1 | $3.64M | Buy |
67,599
+2,537
| +4% | +$145K | 0.03% | 663 |
|
|
2014
Q4 | $3.64M | Buy |
65,062
+319
| +0.5% | +$16.9K | 0.03% | 699 |
|
|
2014
Q3 | $3.35M | Buy |
64,743
+1,076
| +2% | +$58.6K | 0.02% | 706 |
|
|
2014
Q2 | $3.57M | Sell |
63,667
-52,556
| -45% | -$2.73M | 0.02% | 717 |
|
|
2014
Q1 | $6.02M | Buy |
116,223
+57,617
| +98% | +$3.23M | 0.04% | 451 |
|
|
2013
Q4 | $3.35M | Buy |
58,606
+1,060
| +2% | +$57.1K | 0.02% | 714 |
|
|
2013
Q3 | $2.77M | Sell |
57,546
-2,050
| -3% | -$89.5K | 0.02% | 763 |
|
|
2013
Q2 | $2.21M | Buy |
+59,596
| New | +$2.05M | 0.02% | 837 |
|
Other funds holding ALGN
N
Metropolitan Life Insurance Company (MetLife)'s ALGN Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Align Technology (ALGN) in Q2 2024, closing a stake of 2,873 shares — an estimated $942K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ALGN in Q2 2013 and held it in 44 quarters. The position peaked at $8.39M in Q1 2017. 768 funds tracked by Wall St. Rank hold ALGN as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Align Technology position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,873 Align Technology shares in Q2 2024, an estimated $942K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Align Technology in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Align Technology position peaked at $8.39M in Q1 2017.
- 768 funds tracked by Wall St. Rank held Align Technology as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.